The trial will be a collaborative effort between the company, the Norwegian Cancer Society, and Cancer Research UK.

Activated b-catenin or loss of its negative regulator adenomatous polyposis coli (APC) is a potential biomarker for NT219 in ...

More information: Yi-Wei Tsai et al, N-Cadherin promotes cardiac regeneration by potentiating pro-mitotic β-Catenin signaling ...

Bergen, Norway, April 23, 2025 – Cytovation ASA, a clinical stage oncology company focused on the development of its first-in-class bifunctional peptide CY-101, announces that it has raised NOK62 ...